Research into rare disease has led to new treatments and some breakthroughs. But are the policies and science aligned to produce treatments?…
The hotly anticipated 7th Annual CAR-TCR Summit is back, bigger and better than ever, uniting experts with one common goal: engineering a di…
The new JAMA editor-in-chief, health equity advocate Kirsten Bibbins-Domingo, M.D., Ph.D., M.A.S., will share how she plans to steer the pre…
Despite all of their promise, newer medicines, especially those based on advanced technologies, have been met with unprecedented challenges …
Like approaching asteroids, major biosimilars for Humira and other drugs are finally due to hit the market in 2023. Should we brace for impa…
A multi-year pandemic has brought no end of trials, but also plenty of triumphs. Come for two days of silo-breaking and solution-focused dis…
Join top pharma and biotech leaders, the foremost technology innovators in clinical development and healthcare, regulatory authorities, pati…
Featured
